Loading company…
Beijing-based medical company developing microneedle transdermal drug delivery technology, founded in 2018.
Founded in 2018 and based in Beijing, China, Zhongke Weizhen researches and develops microneedle transdermal drug delivery technologies, along with medical devices and cosmetics. It was recognized as a National High-tech Enterprise and has a branch office in Chongqing. Its product lines cover metabolic, anesthesia, oncology and central nervous system series for pharmaceutical companies and the medical aesthetic industry. In April 2020 it closed a pre-series A round from unspecified investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in